Feline leukemia virus trans-membrane protein p15E for diagnosis of FeLV infection
US10261082B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2016 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Oct 15, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/13022
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides for a method for the detection of FeLV infection in a patient, wherein a sample obtained from the patient is contacted in-vitro with a recombinant transmembrane p15E protein in a p15 (E) antibody binding step.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.